BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3361753)

  • 21. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.
    Abe H; Shibuya T; Odashima S; Arichi S; Nagase S
    Nephron; 1988; 50(4):351-5. PubMed ID: 3237275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of anionic sites on the mesangium in aminonucleoside nephrosis.
    Ueda Y; Wada N; Hirabayashi K; Ono H; Iidaka K
    Nihon Jinzo Gakkai Shi; 1989 Oct; 31(10):1001-9. PubMed ID: 2615011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
    Tofovic SP; Rominski BR; Bastacky S; Jackso EK; Kost CK
    Ren Fail; 2000 Mar; 22(2):159-79. PubMed ID: 10803761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation.
    Diamond JR; Karnovsky MJ
    Kidney Int; 1987 Nov; 32(5):671-7. PubMed ID: 3430956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
    Diamond JR; Pesek I
    Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
    Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside.
    Diamond JR; Karnovsky MJ
    Am J Pathol; 1986 Mar; 122(3):481-7. PubMed ID: 3953770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury.
    Diamond JR; Pesek I; Ruggieri S; Karnovsky MJ
    Am J Physiol; 1989 Nov; 257(5 Pt 2):F798-807. PubMed ID: 2589483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH; Boggs KP; Burke FC
    Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization and distribution of anionic charges in the glomerular mesangium of normal and nephrotic rats.
    Grond J; Elema JD
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(2):135-43. PubMed ID: 2581361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
    Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
    Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
    Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low molecular weight heparin in the treatment of puromycin-induced nephrosis.
    Dos Santos AM; de Olveira AV; da Silva Lemos CC; Mandarim-de-Lacerda CA; Bregman R
    Pathol Res Pract; 2006; 202(3):157-63. PubMed ID: 16492522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats.
    Shibouta Y; Terashita Z; Imura Y; Shino A; Kawamura M; Ohtsuki K; Ohkawa S; Nishikawa K; Fujiwara Y
    Kidney Int; 1991 May; 39(5):920-9. PubMed ID: 2067208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A morphometric, biochemical and histochemical comparison of puromycin aminonucleoside and hyperalbuminaemic induced proteinurias in the female Wistar rat.
    Lawrence GM; Brewer DB
    J Pathol; 1983 Feb; 139(2):115-40. PubMed ID: 6827398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
    Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
    Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unilateral renal disease in the rat. II. Glomerular mesangial uptake of colloidal carbon in unilateral aminonucleoside nephrosis and nephrotoxic serum nephritis.
    Hoyer JR; Elema JD; Vernier RL
    Lab Invest; 1976 Mar; 34(3):250-5. PubMed ID: 1082531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin.
    Abboud HE; Ou SL; Velosa JA; Shah SV; Dousa TP
    J Clin Invest; 1982 Feb; 69(2):327-36. PubMed ID: 7056851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.